A detailed history of Bennett Selby Investments LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Bennett Selby Investments LP holds 543 shares of LLY stock, worth $405,186. This represents 0.2% of its overall portfolio holdings.

Number of Shares
543
Previous 512 6.05%
Holding current value
$405,186
Previous $463,000 3.89%
% of portfolio
0.2%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $23,936 - $29,760
31 Added 6.05%
543 $481,000
Q2 2024

Jul 10, 2024

BUY
$724.87 - $909.04 $18,121 - $22,726
25 Added 5.13%
512 $463,000
Q1 2024

Apr 11, 2024

BUY
$592.2 - $792.28 $60,996 - $81,604
103 Added 26.82%
487 $378,000
Q4 2023

Jan 08, 2024

BUY
$525.19 - $619.13 $201,672 - $237,745
384 New
384 $223,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bennett Selby Investments LP Portfolio

Follow Bennett Selby Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bennett Selby Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Bennett Selby Investments LP with notifications on news.